{"cmr":"fr-cm-kg/ALXP/FR0010095596","since":null,"total":26,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-10-28","event_type":"newswire_release","title":"TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc. - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/tenx-stockholder-notice-shareholder-rights-law-firm-robbins-llp-reminds-investors-of-the-class-action-lawsuit-against-tenax-therapeutics-inc-302921469.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"N-iOuMeA4smChlhUNmWL7mGrZdPZOLf3tSkyG_sUuj2Oa7JeZOEyF5A7pvIrZlu-BVJRw2pYVVnLm2Wm5gjrCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-10-11","event_type":"newswire_release","title":"Valerio Therapeutics Completes Acquisition of Etherna ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261011213857/en/Valerio-Therapeutics-Completes-Acquisition-of-Etherna-Immunotherapies-Building-an-Integrated-Targeted-RNA-Platform-to-Accelerate-Progress-Toward-the-Clinic","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rmv7zNAVhwVjaFOuVeUYqp_ykYuOgnwouSAL_4kQ4rQAfJNmheFkKb37-eAT1PbWeiiBx_JTyTZyDt30BepADA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-10-07","event_type":"results","title":"Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261006747184/en/Valerio-Therapeutics-Provides-an-Update-on-Its-Business-and-Presents-Its-Financial-Results-for-the-First-Half-of-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NKOMBBvhKJweXA9hrTV1I5NuyD2aIzX1aJnX6KqXlJbx6JnLDlGS6_dtn_kThJTxgbieVK3FseFLBIzXk5OhBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-09-09","event_type":"newswire_release","title":"CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/capr-deadline-capr-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-capricor-therapeutics-inc-securities-fraud-lawsuit-302873126.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6vHa2wqTkrOlnptdDzS6ldQLKqq1pjQ4EqPvCzxLF4eLNEMXPPDtkTFlCcrxNrpm7vkVwFpBXqUzgNvIbgWkCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-09-06","event_type":"newswire_release","title":"AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/aard-investors-have-opportunity-to-lead-aardvark-therapeutics-inc-securities-fraud-lawsuit-302870529.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Eg_ptcvbw_m8Lu0Hr-49pjdmP2c9wna9c0dfN8Tu6y19NtuOAzmiLW3f77V6XT3IgkSrlm8T72cCRR0g3tzwDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-08-28","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1135202","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1135202","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer VALERIO THERAPEUTICS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hYWG3QXbrKeHP6VVroBH_FuVa58CHNtXH5ppv6fZOuglq_geYpa0VbFJRd0aB3n8XLBhCvM708KXSnNZnBKkAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-08-13","event_type":"newswire_release","title":"SION ALERT: Investigation Launched into Sionna Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/sion-alert-investigation-launched-into-sionna-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-302850214.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0Zju4UqVOnvxciHlJzH36mzt_uzbZ5EuLBZjWFvE3NNZ_4UqD9n_dwgUstNXM94T6H4pPviHNSdPZBCDrxy_AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-06-29","event_type":"newswire_release","title":"Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/talawar-therapeutics-and-jatt-ii-acquisition-corp-announce-definitive-business-combination-agreement-to-create-publicly-listed-biotechnology-company-developing-potentially-best-in-class-bispecifics-for-ii-diseases-302812610.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"K4FCMSPhRhNJnni02aOyV6qxpocTwfmZOuhkAAC6m6spg_-QSo05GKlei7rNXtXqV6Whrkx_wjt_x1fvI0NiAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-06-16","event_type":"newswire_release","title":"4E Therapeutics Acquired by Lilly to Advance Non-Opioid Approach to Chronic Pain - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/4e-therapeutics-acquired-by-lilly-to-advance-non-opioid-approach-to-chronic-pain-302800631.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rf11-wruoHNPKGSnLRQpZ9c3R24bRMXBK3au5qn430xxiIheveztBDlgaARqI_YiTu6P7R93Z3ncvfCtSeAKBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-05-15","event_type":"newswire_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-grace-therapeutics-inc---grce-302773100.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"R93zDAdYpriTElFxk6ZzG6K0YkLF6KbsTh4JKBVjfdvEFh1Tj04VkDVlwle3lHyJTfmLQM-i3PZrgGMwYjHoBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-05-04","event_type":"newswire_release","title":"Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy Approaches","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260504760916/en/Valerio-Therapeutics-Announces-the-Launch-of-InVimmune-a-New-Company-Dedicated-to-Developing-Differentiated-in-Vivo-Cell-Therapy-Approaches","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"IohR7kyHaCqzlrRLuCJUAoKnMuYR5NbQOBZ8IBSDS2s0LN9XP1ct8FqohQMbFnvj_IrN56dJsCB37QYHeAypBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-04-28","event_type":"newswire_release","title":"Valerio Therapeutics Publishes Its 2025 Annual Results and Annual Financial Report, and Confirms the Strategic Transformation of Its Operating Model","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260428078677/en/Valerio-Therapeutics-Publishes-Its-2025-Annual-Results-and-Annual-Financial-Report-and-Confirms-the-Strategic-Transformation-of-Its-Operating-Model","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iXym3h62SFqQJx1CnBZ_MJLf-VDDgrAFbYIPY6sAyp_y8GpwvbwT0bkJmJvrSMfUkmDVMV1BLOveYxubWn_7AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-03-25","event_type":"newswire_release","title":"Outlook Therapeutics Announces Closing of $5.0 Million","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/25/3262571/0/en/outlook-therapeutics-announces-closing-of-5-0-million-public-offering.html","read_by":"Tavily search (wire domains) + URL date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6JCNy2lJstxYvWw-jXkU3nOUVb_mhkac1gEM9MksOyEgjnmcPk2hoR7U5kkk_gJSExAb7RgfdpAy9TFGdeeVDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-03-23","event_type":"newswire_release","title":"Outlook Therapeutics Announces Proposed Public Offering","wire":"GlobeNewswire","source":"GlobeNewswire","url":"http://www.globenewswire.com/news-release/2026/03/23/3260887/0/en/outlook-therapeutics-announces-proposed-public-offering.html","read_by":"Tavily search (wire domains) + URL date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BLK1ihjBnK-sBJjVD24jK0oaxZZ0nR1UshvaunEtrRu6oNINRYwLgoeEwFPyb3s0427b_dUqmhf3WOzJ1CJdBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-02-27","event_type":"newswire_release","title":"Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/27/3246256/0/en/Portnoy-Law-Firm-Announces-Class-Action-on-Behalf-of-Corcept-Therapeutics-Incorporated-Investors.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0MDIpyLFRv3ViG-spFf9BmCXE5tDgZ2QbWRm8UYkWIuCtzx2W3bNDTfdICLFL-LrwxxLBXXNOyFc-abJAuFeCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-01-29","event_type":"newswire_release","title":"CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/cort-investors-have-opportunity-to-join-corcept-therapeutics-incorporated-fraud-investigation-with-the-schall-law-firm-302673494.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UTACcJahDcn-Bl_wx5fpFyiukDY2C6MLS_pJ59kv6-CUB8q-OlT-TAGz7L-tB0JSV1T_QptxrVUyNF8IjaZrCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2026-01-08","event_type":"newswire_release","title":"CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260107135205/en/CORT-Investors-Have-Opportunity-to-Join-Corcept-Therapeutics-Incorporated-Fraud-Investigation-with-the-Schall-Law-Firm","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"np3AqKluHKh-K-J2RCfIj3jf5Se39pF88PfSfRv7uGf5N4xlL1h5InL_ZXre44qAm5XoDAHxZf8_64IP-Ps3Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-12-28","event_type":"newswire_release","title":"INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - TMX Newsfile","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/278616/INVESTIGATION-ALERT-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Tvardi-Therapeutics","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RFCVy8cj7BYl90o9i8UN4VnYVZCPx6gORzEinA56pieAGD42bBVNi3Of0uBDlKHpp9zGUeYEKtvuQR57DQEFDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-12-26","event_type":"newswire_release","title":"Outlook Therapeutics Announces New Employment Inducement","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/26/3210661/0/en/Outlook-Therapeutics-Announces-New-Employment-Inducement-Grants.html","read_by":"Tavily search (wire domains) + URL date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lEgVWryx_j37DVaQVmVzraNaQn2DNPp9aMLY-PHYL_L_iDIQMeXZsYhHa9cizcmJcbtJTNDIadxVsK_8hClcBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-12-17","event_type":"newswire_release","title":"Valerio Therapeutics Announces the Appointment of Professor Eric Vivier as Observer to Its Board of Directors","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251217434027/en/Valerio-Therapeutics-Announces-the-Appointment-of-Professor-Eric-Vivier-as-Observer-to-Its-Board-of-Directors","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"R_XKbnvk0QTvsli5ZypMwW-sLL26JM9nlEmKRd7kbabz8NfdVhY8TWtICBZ9-tfgWCbBZxtfexKbEO4MlLxjDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-12-07","event_type":"newswire_release","title":"TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - Newsfile","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/277133/TVRD-INVESTOR-NOTICE-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Tvardi-Therapeutics","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1gHH_UpNPEMZiMfdsGCVbyzTmLPaZy9z-DLigQUkzRuTt4t9CxAc6pAhuSAtQwjsNxXGWgTNHi5ZAfQeGTyBBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-11-30","event_type":"newswire_release","title":"TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/tvrd-investor-notice-faruqi--faruqi-llp-investigates-claims-on-behalf-of-investors-of-tvardi-therapeutics-302626275.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-l50_lAJ3HLXzIkorj-SnKJwEKxRGcBLf8Il9ej85I8bpgoT8GPW_X2rkA8RvbM4xdE74rvwKx9O9t_6fKOPDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-11-15","event_type":"newswire_release","title":"RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251114981065/en/RPTX-Stock-Alert-Halper-Sadeh-LLC-is-Investigating-Whether-the-Sale-of-Repare-Therapeutics-Inc.-is-Fair-to-Shareholders","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sl0hP6oU1qspHxhQQlks4ixnzcaz6LTD07MX6nVvQEkEcEKiJleOVS7dqs0XWI1CNM-cFtQnqZ5e7NeiNjrmBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-11-12","event_type":"newswire_release","title":"PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251111295778/en/PRLD-Investors-Have-Opportunity-to-Join-Prelude-Therapeutics-Incorporated-Fraud-Investigation-With-the-Schall-Law-Firm","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Uts5O2e9P5wRHR71s44JbTxCebvWkdosFdNiK1BmCIiUZ0qYW18AfP9ShbJFvIoZDUfGqlsauEDK6gCACNFKBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-11-01","event_type":"newswire_release","title":"TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251031549353/en/TVRD-Investors-Have-Opportunity-to-Join-Tvardi-Therapeutics-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"G-JHHkeB-C9n9D2v1xZUS0Uetdev_ypUR1raSUoA6IttcGjJfIoCMQ7E2oIQmks7BXkszyBeydHpZfsmSrICDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0010095596","date":"2025-10-16","event_type":"newswire_release","title":"LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251015747762/en/LRMR-Investors-Have-Opportunity-to-Join-Larimar-Therapeutics-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'therapeutics'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XVUAAFhKxNGrq3sOJOctoSjUG4f3Ik3qEcEr8RlFsTue_Vq2gXWNfqKN9aU-DLrM_KK_ZwKeqK1WOvpsap7WDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}